FDA Gives Insight On Changing Approval Landscape
Executive Summary
Device center officials at the US agency focused on new approval pathways at RAPS Convergence 2020.
You may also be interested in...
Cognoa Seeks De Novo Clearance For AI-Powered Diagnostic App For Autism After Successful Study
FDA clearance of the ASD Diagnostic app could lead to early diagnosis, improving quality of life of children with ASD and their caregivers.
FDA Finalizes First Two Guidances For 510(k) Pathway That Uses Performance Measurements
The guidances outline testing and performance criteria for Foley catheters and cutaneous electrodes submissions through the new abbreviated 510(k) pathway.
Minding The Middle: FDA Fleshes Out De Novo Regs As The Program Expands
A new proposed rule on the de novo classification process does not advance any major policy reforms, but its release underscores the growing popularity of the regulatory pathway that provides flexibility for US FDA and industry in the space between 510(k)s and PMAs.